135 related articles for article (PubMed ID: 20518409)
21. Patients with negative cervical biopsies after papanicolaou test interpretations of "atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion": comparative longitudinal follow-up.
Huitron S; Bonvicino A; Fadare O
Ann Diagn Pathol; 2008 Jun; 12(3):187-90. PubMed ID: 18486894
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C
Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169
[TBL] [Abstract][Full Text] [Related]
23. Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear.
Molden T; Nygård JF; Kraus I; Karlsen F; Nygård M; Skare GB; Skomedal H; Thoresen SO; Hagmar B
Int J Cancer; 2005 May; 114(6):973-6. PubMed ID: 15645423
[TBL] [Abstract][Full Text] [Related]
24. [The Pap test in HIV-positive women].
Carlucci M; Cimmino A; Fiore MG; Lepera A; Tantimonaco L; Ricco R
Pathologica; 2001 Dec; 93(6):651-3. PubMed ID: 11785116
[TBL] [Abstract][Full Text] [Related]
25. Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.
Wu T; Chen X; Zheng B; Li J; Xie F; Ding X; Zeng Z; Zhao C
J Am Soc Cytopathol; 2019; 8(4):206-211. PubMed ID: 31272603
[TBL] [Abstract][Full Text] [Related]
26. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
[TBL] [Abstract][Full Text] [Related]
27. The Italian experience of a Pap test and speculoscopy based screening programme.
Boselli F; De Martis S; Rivasi F; Toni A; Abbiati R; Chiossi G
J Med Screen; 2000; 7(3):160-2. PubMed ID: 11126166
[TBL] [Abstract][Full Text] [Related]
28. High-Risk Human Papillomavirus Testing, Genotyping, and Histopathologic Follow-up in Women With Abnormal Glandular Cells on Papanicolaou Tests.
Zuo T; Levi AW; Lin Q; Abi-Raad R; Adeniran AJ; Cai G
Am J Clin Pathol; 2021 Sep; 156(4):569-576. PubMed ID: 33728437
[TBL] [Abstract][Full Text] [Related]
29. The pre- and postoperative value of endocervical curettage in the detection of cervical intraepithelial neoplasia and invasive cervical cancer.
Fine BA; Feinstein GI; Sabella V
Gynecol Oncol; 1998 Oct; 71(1):46-9. PubMed ID: 9784317
[TBL] [Abstract][Full Text] [Related]
30. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
Guo M; Khanna A; Wang J; Dawlett MA; Kologinczak TL; Lyons GR; Bassett RL; Sneige N; Gong Y; Bevers TB
Cancer Cytopathol; 2017 Aug; 125(8):644-651. PubMed ID: 28498639
[TBL] [Abstract][Full Text] [Related]
31. Pap smears with reactive cellular changes: a prospective study.
Ding DC; Hsu S; Chen SS; Hsu YH
J Reprod Med; 2007 Oct; 52(10):938-40. PubMed ID: 17977169
[TBL] [Abstract][Full Text] [Related]
32. Assessment of reflex human papillomavirus DNA testing in patients with atypical endocervical cells on cervical cytology.
Chen L; Yang B
Cancer; 2008 Aug; 114(4):236-41. PubMed ID: 18548530
[TBL] [Abstract][Full Text] [Related]
33. Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program : a prospective randomized study.
Strander B; Andersson-Ellström A; Milsom I; Rådberg T; Ryd W
Cancer; 2007 Oct; 111(5):285-91. PubMed ID: 17724676
[TBL] [Abstract][Full Text] [Related]
34. A study of 10,296 pediatric and adolescent Papanicolaou smear diagnoses in northern New England.
Mount SL; Papillo JL
Pediatrics; 1999 Mar; 103(3):539-45. PubMed ID: 10049953
[TBL] [Abstract][Full Text] [Related]
35. Impact of a Modified HistoGel Method for Processing Endocervical Curettage Specimens on Diagnostic Yield.
Ramia de Cap M; Jou D; Chen Y; Hecht JL; VanderLaan PA; Chen AL
Am J Clin Pathol; 2021 Jan; 155(1):141-147. PubMed ID: 33009570
[TBL] [Abstract][Full Text] [Related]
36. Cervical cancer screening with liquid cytology in women with developmental disabilities.
Kavoussi SK; Smith YR; Ernst SD; Quint EH
J Womens Health (Larchmt); 2009; 18(1):115-8. PubMed ID: 19072727
[TBL] [Abstract][Full Text] [Related]
37. Triage of women with atypical squamous cells of undetermined significance (ASC-US): results of an Italian multicentric study.
Del Mistro A; Frayle-Salamanca H; Trevisan R; Matteucci M; Pinarello A; Zambenedetti P; Buoso R; Fantin GP; Zorzi M; Minucci D
Gynecol Oncol; 2010 Apr; 117(1):77-81. PubMed ID: 20116836
[TBL] [Abstract][Full Text] [Related]
38. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
Liao SY; Stanbridge EJ
Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
[TBL] [Abstract][Full Text] [Related]
39. Presence of 10 transformation zone cells in endocervical curettage should not be required for adequacy.
Alqabbani R; Chan J; Goldberg A
Am J Clin Pathol; 2024 Apr; 161(4):369-373. PubMed ID: 38035727
[TBL] [Abstract][Full Text] [Related]
40. Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer.
Costa S; Sideri M; Syrjänen K; Terzano P; De Nuzzo M; De Simone P; Cristiani P; Finarelli AC; Bovicelli A; Zamparelli A; Bovicelli L
Acta Cytol; 2000; 44(3):310-8. PubMed ID: 10833984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]